Brief: Lisata Therapeutics Announces First Patient Treated In Bolster Trial Of Lsta1, A Novel Tumor-Targeting And Penetrating Peptide, In Patients With Advanced Solid Tumors
12/09/2023 14:32
Sept 12 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES FIRST PATIENT TREATED IN
BOLSTER
TRIAL OF LSTA1, A NOVEL TUMOR-TARGETING AND PENETRATING PEPTIDE,
IN PATIENTS WITH ADVANCED SOLID TUMORS
Source text for Eikon: ID:nGNXcdgnKb
Further company coverage: LSTA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco